Eli Lilly and Co (LLY)

Hedge Fund and Insider Trading News: Ken Griffin, Bill Ackman, York Capital Management, Berkshire Hathaway, Elliott Management, Tiger Global Management, Humana Inc (HUM), 3M Co (MMM), and More

Citadel Sees Most U.S. Staff Returning to the Office by June 1 (Bloomberg) Ken Griffin’s Citadel expects to have most of its U.S. employees back in...

Keep Reading →

May 4 - Hedge Funds, Insider Trading - Comments

Insiders Buying Into the Huge Rallies in Evolus (EOLS), Verastem (VSTM)

Insiders are masters of snatching up shares of their companies at a discount, expanding their positions during weakness in the stock. In contrast, they...

Keep Reading →

June 18 - Insider Trading, Market Movers, News - Comments

17 Most Drug Addicted Countries in the World in 2017

5 Opioid Treatment Stocks

The five opioid treatment stocks are among several companies that have taken their own approach to the growing opioid addiction market in the US, which...

Keep Reading →

February 5 - Lists, News - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

15 Best Selling Most Profitable Drugs of All Time

Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest...

Keep Reading →

November 24 - News - Comments

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

What’s Going On In The Finance World Today?

1. US Stock Market: “U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while...

Keep Reading →

April 17 - Commodities, Gold, Market Movers, News, Tech - Comments

Eli Lilly And Co (LLY) Taltz Has A Higher Response Rate Than Stelara For Psoriasis

Detailed results from the IXORA-S study have revealed that Taltz (ixekizumab) has superior efficacy compared to Stelara (ustekinumab). According to Eli...

Keep Reading →

March 8 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks

By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system....

Keep Reading →

February 23 - News, Stock Analysis - Comments

Trulicity Label From Eli Lilly And Co (LLY) Will Be Used In Combination With Basal Insulin

The once per week Trulicity label from Eli Lilly and Co (NYSE:LLY) has been updated. The changes, which have been approved by the U.S. Food and Drug Administration...

Keep Reading →

February 9 - News, Stock Analysis - Comments

Can Acorda Therapeutics Inc (ACOR) Give Eli Lilly And Co (LLY) A Run For Its Money In Migraine Drug Market?

Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE...

Keep Reading →

January 24 - News, Stock Analysis - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Here’s What You Need To Know About The Eli Lilly And Co (LLY) And CoLucid Pharmaceuticals Inc (CLCD) Deal

Eli Lilly and Co (NYSE:LLY) just announced that it is set to acquire junior biotech CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) in a deal worth up to $960...

Keep Reading →

January 19 - News, Stock Analysis - Comments

abdomen, asian, batten, belly, big, body, boy, cellulite, check, child, children, concept, diabetes, diet, excess, fat, hand, health, healthy, heart, kid, kids, lung, male, obese, obesity, overweight, pressure, stethoscope, stomach, thick, unhealthy, weight, young

11 Fattest Countries in The World

The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and...

Keep Reading →

January 17 - Lists, News - Comments

Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider

After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences...

Keep Reading →

December 23 - News, Stock Analysis - Comments

gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly And Co (LLY)

AstraZeneca plc (ADR) (NYSE:AZN) has recently unveiled how it plans to transform its US Commercial segment as part of its broader growth strategy. “...

Keep Reading →

December 9 - News, Stock Analysis - Comments

Eli Lilly And Co (LLY) Discusses Job Cuts

Eli Lilly and Co (NYSE:LLY) has recently confirmed that it will cut jobs following the release of disappointing results from a clinical trial evaluating...

Keep Reading →

December 8 - News, Stock Analysis - Comments

Pfizer Inc. (PFE), Eli Lilly And Co (LLY) Impotence Drugs Price Increases Leave Patients Disgruntled

Pfizer Inc. (NYSE:PFE) and Eli Lilly and Co (NYSE:LLY) are yet again the subject of immense criticism as their practice of increasing the prices of key...

Keep Reading →

November 29 - News, Stock Analysis - Comments

Here’s Why These Two Biotechs Just Took A Hit: Eli Lilly And Co (LLY) And Juno Therapeutics Inc (JUNO)

As the markets take a break for Thanksgiving, things settled down a little bit late-Wednesday, but not before some sharp shocks in the biotech sector....

Keep Reading →

November 24 - Market Movers, News, Stock Analysis - Comments

Biogen Inc (BIIB) Stock Tumbles In Sympathy To Eli Lilly And Co (LLY), C’mon Man!

Biogen Inc (NASDAQ:BIIB) stock is getting whacked in sympathy to Eli Lilly and Co (NYSE:LLY)‘s announcement that it has once again failed in its...

Keep Reading →

November 23 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, internet, male, drugstore, service,

Eli Lilly And Co (LLY) Stock: Falling Apart On Failed Study

Eli Lilly And Co (NYSE:LLY) is having an incredibly rough day in the market today. After starting the day off in the red, the stock has fallen further...

Keep Reading →

November 23 - News, Stock Analysis - Comments

Trending Stocks: First Solar, Inc. (FSLR), Eli Lilly and Co (LLY), and More

On the day before Thanksgiving, five stocks, First Solar, Inc. (NASDAQ:FSLR), Medtronic PLC (NYSE:MDT), Eli Lilly and Co (NYSE:LLY), Axovant Sciences...

Keep Reading →

November 23 - News - Comments

Eli Lilly and Co (LLY) Gets Dedicated Humulin R U-500 Insulin Syringe From Becton Dickinson

Becton Dickinson (BD) has recently unveiled BD U-500 Insulin Syringe, a syringe dedicated to the Humulin R U-500 insulin of Eli Lilly and Co (NYSE:LLY...

Keep Reading →

November 10 - News, Stock Analysis - Comments

Eli Lilly And Co (LLY) Is Awaiting the FDA’s Nod Over a New Indication for Jardiance

Eli Lilly and Co (NYSE:LLY) has categorically stated to its regulators and investors that it is hanging onto a possible nod from the FDA for a new indication...

Keep Reading →

November 2 - News, Stock Analysis - Comments

Billionaire Steve Cohen's Top 10 stock picks

Five Dividend Stocks Billionaire Steve Cohen Really Likes

Although his family office isn’t technically a hedge fund anymore (a settlement with the SEC saw to that), many on Wall Street still regard billionaire...

Keep Reading →

September 19 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News - Comments

Inside The FDA: Eli Lilly and Co (LLY) Jardiance Aims at Proving Cardiovascular Benefit in Diabetes, Will FDA Agree?

Introduction On June 28, 2016, the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration (FDA) met to discuss and...

Keep Reading →

September 9 - News, Stock Analysis - Comments

Why Are Hedge Funds In Love With Eli Lilly (LLY)?

Eli Lilly and Co (NYSE:LLY) is one of the largest drug companies in the world. In this article, we’ll take a closer look at why many hedge funds...

Keep Reading →

September 2 - Hedge Funds, News, Stock Analysis - Comments

Massive Insider Selling at Northrop Grumman (NOC) and Chinese Biotech, While Insider Buying Observed at 3 Other Companies

Peter Lynch, the former manager of the Magellan Fund at Fidelity Investments, once said that “Insiders might sell their shares for any number of reasons...

Keep Reading →

August 17 - Insider Trading, News - Comments

Richest Countries in the World by Natural Resources

Why These Five Stocks Are Trending on Tuesday

With the earnings season ongoing, the US stock market is mixed with Dow Jones trading lower, while S&P 500 and NASDAQ have inched up. Among the stocks...

Keep Reading →

July 26 - Earnings Report, News, Tech - Comments

How Viking Global’s Top New Picks in Q1 Performed in Q2

Billionaire Andreas Halversen‘s Viking Global has generated outstanding returns for its investors ever since its inception in 1999, ranking as ...

Keep Reading →

July 25 - Hedge Fund Analysis, Hedge Funds, News - Comments

medicine, diabetes, glycemia, health care,patient, insulin-deficient, middle, app, measurement, male, disease, hypoglycemia, level, technology, medicine, mobile, checking, body, home, smartphone, hyperglycemia, stripe, part, health, indoors, man, glucometer, healthcare, test, human, diabetic, aged, medical, unhealthy, concept, gadget, ill, diabetes, sick, glucose, care, problem, person, cell, sugar, control, application, phone, blood, hand, insulin

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362...

Keep Reading →

June 22 - News, Stock Analysis - Comments

Earnings Wrap: Here’s How These 5 Companies Did Last Quarter

There’s been a slew of earnings reports come in over the past 24 hours, with Procter & Gamble Co (NYSE:PG), 3M Co (NYSE:MMM), E I Du Pont De...

Keep Reading →

April 26 - Market Movers, News - Comments

Intensifying Insider Selling Activity at Eli Lilly and Co (LLY), Exxon Mobil Corporation (XOM) and Edwards Lifesciences Corp (EW)

U.S equities’ awful start to 2016 is gradually getting even worse, which could make investors conclude that the ratio of insider selling to insider...

Keep Reading →

February 9 - Insider Trading, News - Comments

Billionaire Steve Cohen Is Bullish On These Dividend Stocks

In a career spanning over three and a half decades, billionaire Steve Cohen has made a name for himself as being one of the best traders in the world...

Keep Reading →

January 7 - Dividend Stocks, Hedge Funds, News - Comments

Why Are These Stocks Trending Today?

With the VIX above 20 and many investors on edge over the jump in volatility in recent days, Eli Lilly and Co (NYSE:LLY), Willis Towers Watson (NASDAQ...

Keep Reading →

January 5 - Market Movers, News, Tech - Comments

Billionaire Steve Cohen Aggressively Bought These 5 Stocks In Q3

Steve Cohen built a strong reputation and personal fortune for himself while managing hedge fund S.A.C Capital Advisors from 1992 until early 2014, when...

Keep Reading →

November 19 - Hedge Fund Analysis, Hedge Funds, News - Comments

Why Are These Healthcare Stocks Making Big Moves Today?

The week’s trading is underway and several biotech stocks are hot out of the gates, making big early morning gains. On the other hand, one stock broke...

Keep Reading →

October 12 - Hedge Funds, Market Movers, News - Comments

Data Show Hedge Funds Like One of these Two Volatile Healthcare Stocks More than the Other

Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions...

Keep Reading →

September 29 - Market Movers, News - Comments

Twitter, is TWTR a good stock to buy, Aliza Knox,

Twitter Inc (TWTR), Lions Gate Entertainment Corp. (USA) (LGF) and Eli Lilly and Co (LLY) Are Top Choices for Monday Trading: Fast Money Crew

Top picks for Monday’s trading by CNBC‘s Fast Money Crew seem to be across the board. Twitter Inc (NYSE:TWTR) represented the technology sector...

Keep Reading →

January 11 - News, Tech - Comments

Loss of Patents Main Cause of Lower Earnings at Eli Lilly and Co (LLY)

The loss of Patents over the years, has been the main cause of lower earnings at Eli Lilly and Co (NYSE:LLY), the CEO of the company, Dr. John Lechleiter...

Keep Reading →

July 24 - News - Comments

Posts Tagged ‘Eli Lilly and Co (LLY)’